GE Healthcare has agreed to distribute Confirma's CADstream, which highlights and color-codes suspicious areas of the breast, while automatically correcting MR images for patient movements. CADstream has the potential to streamline workflow with features
GE Healthcare has agreed to distribute Confirma's CADstream, which highlights and color-codes suspicious areas of the breast, while automatically correcting MR images for patient movements. CADstream has the potential to streamline workflow with features including image registration, subtractions, angiogenesis maps, interactive real-time contrast curves, multiplanar reformatting, maximum intensity projections, and volume summaries.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.